Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 79551 - 79575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Thimerosal	Approved	WIPF3	644150	downregulated	Thimerosal results in decreased expression of WIPF3 mRNA	7p14.3	A21035
Thimerosal	Approved	WNK1	65125	downregulated	Thimerosal results in decreased expression of WNK1 mRNA	12p13.33	A21035
Thimerosal	Approved	WNT3	7473	downregulated	Thimerosal results in decreased expression of WNT3 mRNA	17q21.31-q21.32	A21035
Lipoic acid	Approved Investigational Nutraceutical	CAT	847	upregulated	Thioctic Acid results in increased expression of CAT mRNA	11p13	A24425
Lipoic acid	Approved Investigational Nutraceutical	GCLC	2729	upregulated	Thioctic Acid results in increased expression of GCLC mRNA	6p12.1	A24426 A24427
Lipoic acid	Approved Investigational Nutraceutical	GCLM	2730	upregulated	Thioctic Acid results in increased expression of GCLM mRNA	1p22.1	A24426
Lipoic acid	Approved Investigational Nutraceutical	GPX1	2876	upregulated	Thioctic Acid results in increased expression of GPX1 mRNA	3p21.31	A24425
Lipoic acid	Approved Investigational Nutraceutical	GPX3	2878	upregulated	Thioctic Acid results in increased expression of GPX3 mRNA	5q33.1	A24425
Lipoic acid	Approved Investigational Nutraceutical	GPX5	2880	upregulated	Thioctic Acid results in increased expression of GPX5 mRNA	6p22.1	A24425
Lipoic acid	Approved Investigational Nutraceutical	GSR	2936	upregulated	Thioctic Acid results in increased expression of GSR mRNA	8p12	A24425
Lipoic acid	Approved Investigational Nutraceutical	HMOX1	3162	upregulated	Thioctic Acid results in increased expression of HMOX1 mRNA	22q12.3	A22397 A24425
Lipoic acid	Approved Investigational Nutraceutical	NFE2L2	4780	upregulated	Thioctic Acid results in increased expression of NFE2L2 mRNA	2q31.2	A24425
Lipoic acid	Approved Investigational Nutraceutical	NQO1	1728	upregulated	Thioctic Acid results in increased expression of NQO1 mRNA	16q22.1	A24427 A22397 A24425
Tioguanine	Approved Investigational	IMPDH2	3615	upregulated	Thioguanine results in increased expression of IMPDH2 mRNA	3p21.31	A21018
Thiopental	Approved Investigational Vet Approved Withdrawn	HSP90AA1	3320	upregulated	Thiopental results in increased expression of HSP90AA1 mRNA	14q32.31	A24428
Thiopental	Approved Investigational Vet Approved Withdrawn	HSPB1	3315	upregulated	Thiopental results in increased expression of HSPB1 mRNA	7q11.23	A24428
Thioridazine	Approved Withdrawn	AP1S1	1174	downregulated	Thioridazine results in decreased expression of AP1S1 mRNA	7q22.1	A20438 A20430
Thioridazine	Approved Withdrawn	ASAH1	427	upregulated	Thioridazine results in increased expression of ASAH1 mRNA	8p22	A20430
Thioridazine	Approved Withdrawn	ASNS	440	upregulated	Thioridazine results in increased expression of ASNS mRNA	7q21.3	A20430
Thioridazine	Approved Withdrawn	CRH	1392	downregulated	Thioridazine results in decreased expression of CRH mRNA	8q13.1	A21633
Thioridazine	Approved Withdrawn	FABP1	2168	upregulated	Thioridazine results in increased expression of FABP1 mRNA	2p11.2	A20438 A20430
Thioridazine	Approved Withdrawn	FNDC4	64838	upregulated	Thioridazine results in increased expression of FNDC4 mRNA	2p23.3	A20438 A20430
Thioridazine	Approved Withdrawn	GDPD3	79153	upregulated	Thioridazine results in increased expression of GDPD3 mRNA	16p11.2	A20430
Thioridazine	Approved Withdrawn	HPN	3249	upregulated	Thioridazine results in increased expression of HPN mRNA	19q13.11	A20438
Thioridazine	Approved Withdrawn	INHBE	83729	upregulated	Thioridazine results in increased expression of INHBE mRNA	12q13.3	A20438 A20430

Displaying entries 79551 - 79575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability